These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13567287)

  • 1. Current therapeutics. 127. Warfarin; a new coumarin anticoagulant.
    SISE HS
    Practitioner; 1958 Jul; 181(1081):98-102. PubMed ID: 13567287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new anticoagulant derived from coumarin: 1-methoxy-2, 2-bis(4-hydroxy-3-coumarinyl)-ethane].
    DELAHAYE JP; PLAUCHU G; FROMENT A
    Lyon Med; 1963 May; 209():1147-59. PubMed ID: 14026605
    [No Abstract]   [Full Text] [Related]  

  • 3. [Critical study of the use of a new anticoagulant, derived from coumarin: dicoumoxyl, 1-methoxy-2,2-bis (4-hydroxy-3-coumarinyl)-ethane].
    DELBOY C
    Gaz Med Fr; 1963 Feb; 70():735-42. PubMed ID: 14026667
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.
    Koch E; Biber A
    Phytomedicine; 2007; 14 Suppl 6():40-5. PubMed ID: 17188479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new coumarin derivative anticoagulant: sintrom (G 23350); clinical & experimental researches].
    RAVERA M
    Minerva Med; 1957 Apr; 48(27):1126-30. PubMed ID: 13440688
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new anticoagulant of the coumarin series: sinthrome, 3-(2-acetyl-1-p-nitrophenyl-ethyl)-4-hydroxycoumarin].
    FERRARI A; SIDERI G; VERGANI G
    Osp Maggiore; 1958 Mar; 46(3):89-94. PubMed ID: 13566827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient with warfarin poisoning caused by coumarin rodenticide].
    Matsuda K; Okamoto M; Higaki A; Konno Y; Tohyama K; Ichihara K; Suzuki K
    Chudoku Kenkyu; 2008 Apr; 21(2):169-75. PubMed ID: 18516942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New caged coumarin fluorophores with extraordinary uncaging cross sections suitable for biological imaging applications.
    Zhao Y; Zheng Q; Dakin K; Xu K; Martinez ML; Li WH
    J Am Chem Soc; 2004 Apr; 126(14):4653-63. PubMed ID: 15070382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
    Penka M; Buliková A; Gumulec J; Matýsková M; Smejkal P; Kissová J; Slechtová M; Chlupová G
    Vnitr Lek; 2006 Mar; 52 Suppl 1():35-40. PubMed ID: 16637448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new coumarin glucoside, coumarins and alkaloids from Ruta corsica roots.
    Bertrand C; Fabre N; Moulis C
    Fitoterapia; 2004 Mar; 75(2):242-4. PubMed ID: 15030936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.
    Hazai E; Visy J; Fitos I; Bikádi Z; Simonyi M
    Bioorg Med Chem; 2006 Mar; 14(6):1959-65. PubMed ID: 16290938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experiences with the anticoagulant warfarin sodium (coumadin sodium).
    PORTER RR; RICHARDSON D; MAUCK HP
    Va Med Mon (1918); 1958 Sep; 85(9):465-71. PubMed ID: 13581501
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of coumarin derivatives as anti-fungal agents against soil-borne fungal pathogens.
    Brooker NL; Kuzimichev Y; Laas J; Pavlis R
    Commun Agric Appl Biol Sci; 2007; 72(4):785-93. PubMed ID: 18396811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
    Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building addressable libraries: site selective coumarin synthesis and the "real-time" signaling of antibody-coumarin binding.
    Tesfu E; Roth K; Maurer K; Moeller KD
    Org Lett; 2006 Feb; 8(4):709-12. PubMed ID: 16468748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenated coumarin derivatives as novel seed protectants.
    Brooker N; Windorski J; Bluml E
    Commun Agric Appl Biol Sci; 2008; 73(2):81-9. PubMed ID: 19226745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new synthetic anticoagulant: 3-(l'fenyl-propyl)-4-idroxycoumarin].
    GAGLIARDI L
    Gazz Med Ital; 1953 Nov; 112(11):303-8. PubMed ID: 13142280
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term anticoagulation: the prospects for alternatives to warfarin.
    Ansell J
    Semin Vasc Surg; 2005 Sep; 18(3):134-8. PubMed ID: 16168888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.